News
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...
Lilly said it would report data from another trial for the pill for weight management later in the year. It plans to file for ...
It recently disclosed inventory, valued at nearly $550 million ... Another GLP-1 pill, Rybelsus, is made by Novo Nordisk and approved to treat only diabetes. It is the same drug as Wegovy and ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications ... In 2020, the US Food and Drug Administration approved Novo Nordisk’s Rybelsus for treatment ...
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results